Zinc and selenium levels measured in patients treated with rosuvastatin + mineral supplement or placebo.

Data are median (25–75% interquartile range).1 Difference in response between rosuvastatin + Zn,Se or placebo groups after treatment, with a 95% confidence interval.2 P-values indicate differences between rosuvastatin + Zn,Se or placebo groups after treatment.Number of participants with missing data: Plasma zinc and Erythrocyte zinc (02 rosuvastatin+ Zn,Se group; 02 rosuvastatin+placebo group).Zinc and selenium levels measured in patients treated with rosuvastatin + mineral supplement or placebo.数据以中位数（四分位距25%~75%）表示。 1 治疗后瑞舒伐他汀（rosuvastatin）联合Zn、Se组与安慰剂组的应答差异，附带95%置信区间。 2 P值用于反映治疗后瑞舒伐他汀+Zn、Se组与安慰剂组的组间差异。 缺失数据的受试者例数：血浆锌与红细胞锌（瑞舒伐他汀+Zn、Se组2例；瑞舒伐他汀+安慰剂组2例）。 本数据集涵盖接受瑞舒伐他汀联合矿物质补充剂或安慰剂治疗的患者的锌与硒水平检测数据。